Kate Luisi

Title: The Innovative Contributions of Kate Luisi

Introduction

Kate Luisi is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of modified cytomegalovirus proteins. With a total of 3 patents to her name, Luisi's work has the potential to impact medical research and therapeutic applications.

Latest Patents

Luisi's latest patents focus on mutant human cytomegalovirus (HCMV) pentamer complex polypeptides. These patents describe methods of making these polypeptides and their use in HCMV protein complexes and compositions. In particular, the modified HCMV polypeptides are designed to stabilize HCMV complexes or unmask a pentamer epitope, which could lead to advancements in understanding and treating HCMV-related diseases.

Career Highlights

Kate Luisi is currently associated with GlaxoSmithKline Biologicals SA, where she continues to innovate in her field. Her work has garnered attention for its potential applications in vaccine development and therapeutic interventions.

Collaborations

Luisi collaborates with notable colleagues, including Enrico Malito and Matthew James Bottomley. These partnerships enhance her research and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Kate Luisi's innovative work in the field of biotechnology, particularly her patents related to cytomegalovirus proteins, showcases her significant contributions to medical research. Her collaborations and career at GlaxoSmithKline Biologicals SA further highlight her impact in the industry.